SCHEMBL3221804

SCHEMBL3221804

CCC=CCC=CCC=CCC=CCCC=CCCC(=O)O

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.96
PPARG P37231 6/20 0.96
CYP19A1 P11511 5/20 0.96
MAPT P10636 5/20 0.96
FFAR1 O14842 4/20 0.96
OXER1 Q8TDS5 3/20 0.96
RXRA P19793 2/20 0.96
PTGS1 P23219 5/20 0.74
PPARA Q07869 5/20 0.74
F7 P08709 4/20 0.74
F3 P13726 4/20 0.74
PPARD Q03181 4/20 0.74
KMT2A Q03164 3/20 0.74
ADORA3 P0DMS8 1/20 0.74
L3MBTL1 Q9Y468 3/20 0.69
KDM4E B2RXH2 2/20 0.69
MEN1 O00255 2/20 0.69
LMNA P02545 2/20 0.69
CYP3A4 P08684 2/20 0.69
HPGD P15428 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL276082 1.00 ALDH1A1 (0.96) ALDH1A1PPARGCYP19A1MAPTFFAR1
SCHEMBL3221528 1.00 ALDH1A1 (0.96) ALDH1A1PPARGCYP19A1MAPTFFAR1
SCHEMBL29225 1.00 ALDH1A1 (0.96) ALDH1A1PPARGCYP19A1MAPTFFAR1
SCHEMBL116899 1.00 ALDH1A1 (0.96) ALDH1A1PPARGCYP19A1MAPTFFAR1
SCHEMBL117314 1.00 ALDH1A1 (0.96) ALDH1A1PPARGCYP19A1MAPTFFAR1
SCHEMBL16269975 1.00 ALDH1A1 (0.96) ALDH1A1PPARGCYP19A1MAPTFFAR1
SCHEMBL742417 1.00 ALDH1A1 (0.96) ALDH1A1PPARGCYP19A1MAPTFFAR1
SCHEMBL16232222 1.00 ALDH1A1 (0.96) ALDH1A1PPARGCYP19A1MAPTFFAR1
SCHEMBL742418 1.00 ALDH1A1 (0.96) ALDH1A1PPARGCYP19A1MAPTFFAR1
SCHEMBL116898 1.00 ALDH1A1 (0.96) ALDH1A1PPARGCYP19A1MAPTFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399516-B2 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR) PRONOVA BIOPHARMA NORGE AS (NO) 2013-03-19 US disclosed
US-20100035990-A1 ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) PRONOVA BIOPHARMA NORGE AS (NO) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035990-A1 ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) PPARG, PPARA, FFAR3 ALDH1A1 1088/4885PPARG 1/4885CYP19A1 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.